1. Home
  2. GEG vs FORA Comparison

GEG vs FORA Comparison

Compare GEG & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GEG

Great Elm Group Inc.

N/A

Current Price

$2.28

Market Cap

69.7M

Sector

Technology

ML Signal

N/A

Logo Forian Inc.

FORA

Forian Inc.

HOLD

Current Price

$2.16

Market Cap

67.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEG
FORA
Founded
1994
2014
Country
United States
United States
Employees
50
N/A
Industry
Computer Software: Prepackaged Software
Computer Software: Prepackaged Software
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
69.7M
67.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GEG
FORA
Price
$2.28
$2.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.3K
62.6K
Earning Date
05-11-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.00
EPS
N/A
N/A
Revenue
N/A
$30,256,919.00
Revenue This Year
N/A
$8.44
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.13
52 Week Low
$1.80
$1.64
52 Week High
$3.51
$2.71

Technical Indicators

Market Signals
Indicator
GEG
FORA
Relative Strength Index (RSI) 62.23 64.06
Support Level $2.03 $2.05
Resistance Level $2.59 $2.20
Average True Range (ATR) 0.07 0.01
MACD 0.00 -0.00
Stochastic Oscillator 63.31 66.67

Price Performance

Historical Comparison
GEG
FORA

About GEG Great Elm Group Inc.

Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: